Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji, T, Yamanishi, K, Tachibana, Y et al. · Intervirology · 1995 · DOI
Quick Summary
This study measured antibodies to three viruses (EBV, HHV-6, and HHV-7) in the blood of ME/CFS patients and healthy controls. Researchers observed that ME/CFS patients had higher antibody levels to all three viruses compared to controls, particularly antibodies to EBV's ZEBRA protein. These findings are consistent with the hypothesis that viral reactivation may occur in ME/CFS, though the study does not establish whether this is a cause or consequence of the illness.
Why It Matters
Viral reactivation has long been hypothesised as a possible factor in ME/CFS pathogenesis, particularly following post-infectious onset. This early study provided evidence that antibody patterns to multiple herpesviruses differ in ME/CFS patients compared to healthy individuals, motivating later investigations into the role of viral persistence and immune dysregulation in this population.
Observed Findings
High EBV antibody titers were observed in most ME/CFS patients.
Antibodies to EBV's ZEBRA protein were detected at higher frequency in ME/CFS patients than in healthy controls.
HHV-6 antibody titers were associated with ME/CFS status compared to controls.
HHV-7 antibody titers were associated with ME/CFS status compared to controls.
The pattern was observed in both post-infectious-onset and non-post-infectious-onset ME/CFS subgroups.
Inferred Conclusions
The authors interpreted elevated and frequent EBV antibodies, particularly ZEBRA antibodies, as consistent with viral reactivation in ME/CFS patients.
The authors suggested that reactivation of all three herpesviruses (EBV, HHV-6, HHV-7) may be associated with ME/CFS.
The post-infectious presentation in some patients was interpreted as supporting a link between acute viral infection and subsequent chronic illness.
Remaining Questions
Does elevated antibody titres reflect active viral reactivation, latent persistence, or altered immune memory?
Are elevated antibodies a cause, consequence, or bystander finding in ME/CFS pathogenesis?
What This Study Does Not Prove
This study does not establish that viral reactivation causes ME/CFS or causes symptom worsening. It does not determine whether elevated antibodies reflect active viral replication, latent persistence, or immune memory. The small sample size (10 per group) and unknown methodological quality limit generalisation beyond these participants. Elevated antibodies alone do not confirm a mechanistic link to ME/CFS pathogenesis.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.